Want the short version?
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
GMED · NYSE · Health Care Equipment
$66.89−1.71 (−2.49%)
Close of Nov 20, 2026, vs Nov 19 · end-of-day
Globus Medical (GMED) · oqro.io/stocks/GMED · printed today. Every figure comes from a public filing, linked on the page online. Not investment advice.
Everything reported about this company, newest first. Each line shows the dates that matter for its source.
Fund moves · Holdings as of Sep 30, 2026 (Q3 2026) · Filed Nov 16, 2026
Bridgewater Associates disclosed a reduced position in GMED for Q3 2026SourceInsider trade · Traded Nov 10, 2026 · Filed Nov 12, 2026
Director sold ~$2.83M of GMED shares in the open marketSourceInsider trade · Traded Nov 10, 2026 · Filed Nov 12, 2026
Director sold ~$303K of GMED shares in the open marketSourcePlanned sale · Planned for Nov 10, 2026 · Notice filed Nov 10, 2026
Director filed to sell about $3.13M of GMED stockSourceInsider trade · Traded Nov 4, 2026 · Filed Nov 5, 2026
Director sold ~$425K of GMED shares in the open marketSourcePlanned sale · Planned for Nov 4, 2026 · Notice filed Nov 4, 2026
Director filed to sell about $425K of GMED stockSourcePolitician trade (House) · Transaction Sep 3, 2026 · Disclosed Oct 12, 2026
Disclosed purchase of GMED — reported range $1,001 - $15,000SourceInsider trade · Traded Sep 15, 2026 · Filed Sep 16, 2026
Director sold ~$2.24M of GMED shares in the open marketSourcePolitician trade (House) · Transaction Aug 19, 2026 · Disclosed Sep 10, 2026
Disclosed purchase of GMED — reported range $15,001 - $50,000SourceFederal contract · Signed Jun 25, 2026 · Updated Aug 20, 2026
Department of Defense awarded GLOBUS MEDICAL INC: $24K obligated to dateSourceInsider trade · Traded Aug 18, 2026 · Filed Aug 19, 2026
Director sold ~$2.18M of GMED shares in the open marketSourceFund moves · Holdings as of Jun 30, 2026 (Q2 2026) · Filed Aug 14, 2026
Sculptor Capital LP disclosed a reduced position in GMED for Q2 2026SourceFund moves · Holdings as of Jun 30, 2026 (Q2 2026) · Filed Aug 14, 2026
Oberweis Asset Management Inc disclosed an increased position in GMED for Q2 2026SourceFund moves · Holdings as of Jun 30, 2026 (Q2 2026) · Filed Jul 29, 2026
Stephens Investment Management Group LLC disclosed an increased position in GMED for Q2 2026SourceFund moves · Holdings as of Jun 30, 2026 (Q2 2026) · Filed Jul 24, 2026
Boston Trust Walden Corp disclosed an increased position in GMED for Q2 2026SourceFund moves · Holdings as of Jun 30, 2026 (Q2 2026) · Filed Jul 23, 2026
Artemis Investment Management LLP disclosed a reduced position in GMED for Q2 2026SourceFund moves · Holdings as of Jun 30, 2026 (Q2 2026) · Filed Jul 10, 2026
Annex Advisory Services, LLC disclosed an increased position in GMED for Q2 2026Federal contract · Signed May 27, 2026 · Updated Jun 25, 2026
Department of Defense awarded GLOBUS MEDICAL INC: $33K obligated to dateSourceInsider trade · Traded Jun 5, 2026 · Filed Jun 9, 2026
Director sold ~$2.02M of GMED shares in the open marketSourceFund moves · Holdings as of Mar 31, 2026 (Q1 2026) · Filed May 22, 2026
Segall Bryant & Hamill, LLC disclosed a reduced position in GMED for Q1 2026SourceFund moves · Holdings as of Mar 31, 2026 (Q1 2026) · Filed May 15, 2026
Sculptor Capital LP disclosed an increased position in GMED for Q1 2026SourceFund moves · Holdings as of Mar 31, 2026 (Q1 2026) · Filed May 15, 2026
Bridgewater Associates disclosed an increased position in GMED for Q1 2026SourceFund moves · Holdings as of Mar 31, 2026 (Q1 2026) · Filed May 15, 2026
Oberweis Asset Management Inc disclosed an increased position in GMED for Q1 2026Fund moves · Holdings as of Mar 31, 2026 (Q1 2026) · Filed Apr 24, 2026
Boston Trust Walden Corp disclosed a reduced position in GMED for Q1 2026SourceFund moves · Holdings as of Mar 31, 2026 (Q1 2026) · Filed Apr 16, 2026
Annex Advisory Services, LLC disclosed an increased position in GMED for Q1 2026SourceFederal contract · Signed Mar 10, 2026 · Updated Apr 16, 2026
Department of Defense awarded GLOBUS MEDICAL INC: $23K obligated to dateSourceFund moves · Holdings as of Mar 31, 2026 (Q1 2026) · Filed Apr 13, 2026
Artemis Investment Management LLP disclosed an increased position in GMED for Q1 2026Federal contract · Signed Jan 28, 2026 · Updated Mar 5, 2026
Department of Defense awarded GLOBUS MEDICAL INC: $31K obligated to dateSourceInsider trade · Traded Feb 25, 2026 · Filed Feb 27, 2026
Officer sold ~$1.89M of GMED shares in the open marketSourceFederal contract · Signed Jan 13, 2026 · Updated Feb 26, 2026
Department of Defense awarded GLOBUS MEDICAL INC: $42K obligated to dateSourceFederal contract · Signed Jan 22, 2026 · Updated Feb 26, 2026
Department of Defense awarded GLOBUS MEDICAL INC: $27K obligated to dateSourceFederal contract · Signed Feb 20, 2026 · Updated Feb 20, 2026
Department of Defense awarded GLOBUS MEDICAL INC: $64K obligated to dateSourceFund moves · Holdings as of Dec 31, 2025 (Q4 2025) · Filed Jan 28, 2026
Boston Trust Walden Corp disclosed an increased position in GMED for Q4 2025SourceFund moves · Holdings as of Dec 31, 2025 (Q4 2025) · Filed Jan 26, 2026
Annex Advisory Services, LLC disclosed a new position in GMED for Q4 2025SourceInsider trade · Traded Jan 8, 2026 · Filed Jan 12, 2026
CFO sold ~$363K of GMED shares in the open marketSourceInsider trade · Traded Jan 8, 2026 · Filed Jan 12, 2026
Director sold ~$202K of GMED shares in the open marketSourceFederal contract · Signed Oct 16, 2025 · Updated Dec 25, 2025
Department of Defense awarded GLOBUS MEDICAL INC: $25K obligated to dateSourceInsider trade · Traded Dec 12, 2025 · Filed Dec 16, 2025
Director sold ~$355K of GMED shares in the open marketSourceInsider trade · Traded Nov 25, 2025 · Filed Nov 28, 2025
Officer sold ~$675K of GMED shares in the open marketSourceFund moves · Holdings as of Sep 30, 2025 (Q3 2025) · Filed Nov 14, 2025
Sculptor Capital LP disclosed an increased position in GMED for Q3 2025SourceFund moves · Holdings as of Sep 30, 2025 (Q3 2025) · Filed Nov 14, 2025
Polar Capital Holdings Plc no longer reported GMED for Q3 2025SourceFund moves · Holdings as of Sep 30, 2025 (Q3 2025) · Filed Nov 14, 2025
Bellevue Group AG disclosed a reduced position in GMED for Q3 2025Fund moves · Holdings as of Sep 30, 2025 (Q3 2025) · Filed Oct 28, 2025
Stephens Investment Management Group LLC disclosed an increased position in GMED for Q3 2025SourceFund moves · Holdings as of Sep 30, 2025 (Q3 2025) · Filed Oct 22, 2025
Vaughan Nelson Investment Management, L.P. no longer reported GMED for Q3 2025SourceFund moves · Holdings as of Sep 30, 2025 (Q3 2025) · Filed Oct 17, 2025
Boston Trust Walden Corp disclosed a new position in GMED for Q3 2025SourceInsider trade · Traded Sep 15, 2025 · Filed Sep 16, 2025
Director sold ~$585K of GMED shares in the open marketSourceFund moves · Holdings as of Jun 30, 2025 (Q2 2025) · Filed Aug 14, 2025
Sculptor Capital LP disclosed an increased position in GMED for Q2 2025SourceFund moves · Holdings as of Jun 30, 2025 (Q2 2025) · Filed Aug 14, 2025
RTW Investments, LP no longer reported GMED for Q2 2025SourceFund moves · Holdings as of Jun 30, 2025 (Q2 2025) · Filed Aug 14, 2025
Driehaus Capital Management LLC no longer reported GMED for Q2 2025SourceFund moves · Holdings as of Jun 30, 2025 (Q2 2025) · Filed Aug 14, 2025
Fuller & Thaler Asset Management, Inc. disclosed a reduced position in GMED for Q2 2025Fund moves · Holdings as of Jun 30, 2025 (Q2 2025) · Filed Jul 29, 2025
William Blair Investment Management, LLC disclosed an increased position in GMED for Q2 2025SourceFund moves · Holdings as of Jun 30, 2025 (Q2 2025) · Filed Jul 21, 2025
Vaughan Nelson Investment Management, L.P. disclosed a reduced position in GMED for Q2 2025SourceFund moves · Holdings as of Mar 31, 2025 (Q1 2025) · Filed May 15, 2025
Freestone Grove Partners LP disclosed an increased position in GMED for Q1 2025SourceFund moves · Holdings as of Jun 30, 2026 (Q2 2026) · Filed Aug 14, 2026
Kennedy Capital Management LLC disclosed a reduced position in GMED for Q2 2026SourceFund moves · Holdings as of Jun 30, 2026 (Q2 2026) · Filed Aug 14, 2026
Bellevue Group AG disclosed a reduced position in GMED for Q2 2026SourceFund moves · Holdings as of Jun 30, 2026 (Q2 2026) · Filed Aug 14, 2026
Bridgewater Associates disclosed an increased position in GMED for Q2 2026SourceFund moves · Holdings as of Jun 30, 2026 (Q2 2026) · Filed Aug 12, 2026
William Blair Investment Management, LLC disclosed a reduced position in GMED for Q2 2026SourceFund moves · Holdings as of Jun 30, 2026 (Q2 2026) · Filed Aug 12, 2026
Segall Bryant & Hamill, LLC disclosed an increased position in GMED for Q2 2026SourceFund moves · Holdings as of Jun 30, 2026 (Q2 2026) · Filed Aug 12, 2026
Fuller & Thaler Asset Management, Inc. disclosed an increased position in GMED for Q2 2026SourceFund moves · Holdings as of Jun 30, 2026 (Q2 2026) · Filed Aug 11, 2026
Clark Capital Management Group, Inc. disclosed an increased position in GMED for Q2 2026SourceFund moves · Holdings as of Mar 31, 2026 (Q1 2026) · Filed May 15, 2026
Bellevue Group AG disclosed a reduced position in GMED for Q1 2026SourceFund moves · Holdings as of Mar 31, 2026 (Q1 2026) · Filed May 14, 2026
Fuller & Thaler Asset Management, Inc. disclosed a reduced position in GMED for Q1 2026SourceFund moves · Holdings as of Mar 31, 2026 (Q1 2026) · Filed May 13, 2026
Kennedy Capital Management LLC disclosed a reduced position in GMED for Q1 2026SourceFund moves · Holdings as of Mar 31, 2026 (Q1 2026) · Filed May 8, 2026
William Blair Investment Management, LLC disclosed a reduced position in GMED for Q1 2026SourceFund moves · Holdings as of Mar 31, 2026 (Q1 2026) · Filed May 5, 2026
Antipodes Partners Ltd disclosed a reduced position in GMED for Q1 2026SourceFund moves · Holdings as of Mar 31, 2026 (Q1 2026) · Filed May 4, 2026
Nicholas Company, Inc. disclosed a reduced position in GMED for Q1 2026SourceFederal contract · Signed Feb 26, 2026 · Updated Apr 9, 2026
Department of Defense awarded GLOBUS MEDICAL INC: $23K obligated to dateSourcePolitician trade (House) · Transaction Mar 3, 2026 · Disclosed Apr 7, 2026
Disclosed purchase of GMED — reported range $1,001 - $15,000SourceFund moves · Holdings as of Dec 31, 2025 (Q4 2025) · Filed Feb 18, 2026
Fuller & Thaler Asset Management, Inc. disclosed a new position in GMED for Q4 2025SourceFund moves · Holdings as of Dec 31, 2025 (Q4 2025) · Filed Feb 17, 2026
Oberweis Asset Management Inc disclosed a new position in GMED for Q4 2025SourceInsider trade · Traded Feb 12, 2026 · Filed Feb 17, 2026
Officer sold ~$877K of GMED shares in the open marketSourceFund moves · Holdings as of Dec 31, 2025 (Q4 2025) · Filed Feb 17, 2026
Bellevue Group AG disclosed a reduced position in GMED for Q4 2025SourceFund moves · Holdings as of Dec 31, 2025 (Q4 2025) · Filed Feb 13, 2026
Sculptor Capital LP disclosed a reduced position in GMED for Q4 2025SourceFund moves · Holdings as of Dec 31, 2025 (Q4 2025) · Filed Feb 13, 2026
Bridgewater Associates disclosed a reduced position in GMED for Q4 2025SourceFund moves · Holdings as of Dec 31, 2025 (Q4 2025) · Filed Feb 13, 2026
Segall Bryant & Hamill, LLC disclosed a reduced position in GMED for Q4 2025SourceFund moves · Holdings as of Dec 31, 2025 (Q4 2025) · Filed Feb 9, 2026
William Blair Investment Management, LLC disclosed a reduced position in GMED for Q4 2025SourceFund moves · Holdings as of Dec 31, 2025 (Q4 2025) · Filed Feb 5, 2026
Antipodes Partners Ltd disclosed an increased position in GMED for Q4 2025SourceFederal contract · Signed Jan 15, 2026 · Updated Feb 5, 2026
Department of Defense awarded GLOBUS MEDICAL INC: $61K obligated to dateSourceFund moves · Holdings as of Dec 31, 2025 (Q4 2025) · Filed Feb 4, 2026
Nicholas Company, Inc. disclosed a reduced position in GMED for Q4 2025SourceFund moves · Holdings as of Dec 31, 2025 (Q4 2025) · Filed Feb 2, 2026
Artemis Investment Management LLP disclosed an increased position in GMED for Q4 2025SourceInsider trade · Traded Nov 12, 2025 · Filed Nov 13, 2025
Director sold ~$2.15M of GMED shares in the open marketSourceInsider trade · Traded Nov 11, 2025 · Filed Nov 13, 2025
Director sold ~$2.11M of GMED shares in the open marketSourceFund moves · Holdings as of Sep 30, 2025 (Q3 2025) · Filed Nov 13, 2025
Bridgewater Associates disclosed an increased position in GMED for Q3 2025SourceFund moves · Holdings as of Sep 30, 2025 (Q3 2025) · Filed Nov 13, 2025
Kennedy Capital Management LLC disclosed an increased position in GMED for Q3 2025SourceFund moves · Holdings as of Sep 30, 2025 (Q3 2025) · Filed Nov 13, 2025
Artemis Investment Management LLP disclosed a reduced position in GMED for Q3 2025SourceFund moves · Holdings as of Sep 30, 2025 (Q3 2025) · Filed Nov 12, 2025
William Blair Investment Management, LLC disclosed an increased position in GMED for Q3 2025SourceFund moves · Holdings as of Sep 30, 2025 (Q3 2025) · Filed Nov 12, 2025
Segall Bryant & Hamill, LLC disclosed an increased position in GMED for Q3 2025SourceFund moves · Holdings as of Sep 30, 2025 (Q3 2025) · Filed Nov 10, 2025
Antipodes Partners Ltd disclosed an increased position in GMED for Q3 2025SourceInsider trade · Traded Nov 7, 2025 · Filed Nov 10, 2025
Director sold ~$648K of GMED shares in the open marketSourceInsider trade · Traded Nov 10, 2025 · Filed Nov 10, 2025
Director sold ~$170K of GMED shares in the open marketSourceFund moves · Holdings as of Jun 30, 2025 (Q2 2025) · Filed Aug 14, 2025
Polar Asset Management Partners Inc. disclosed a reduced position in GMED for Q2 2025SourceFund moves · Holdings as of Jun 30, 2025 (Q2 2025) · Filed Aug 14, 2025
Freestone Grove Partners LP disclosed an increased position in GMED for Q2 2025SourceFund moves · Holdings as of Jun 30, 2025 (Q2 2025) · Filed Aug 14, 2025
Polar Capital Holdings Plc disclosed an increased position in GMED for Q2 2025SourceFund moves · Holdings as of Jun 30, 2025 (Q2 2025) · Filed Aug 13, 2025
Bridgewater Associates disclosed an increased position in GMED for Q2 2025SourceFund moves · Holdings as of Jun 30, 2025 (Q2 2025) · Filed Aug 13, 2025
Kennedy Capital Management LLC disclosed a reduced position in GMED for Q2 2025SourcePolitician trade (House) · Transaction Jun 24, 2025 · Disclosed Aug 13, 2025
Disclosed partial sale of GMED — reported range $1,001 - $15,000SourcePolitician trade (House) · Transaction Jun 17, 2025 · Disclosed Aug 13, 2025
Disclosed purchase of GMED — reported range $1,001 - $15,000SourcePolitician trade (House) · Transaction Jul 10, 2025 · Disclosed Aug 13, 2025
Disclosed sale of GMED — reported range $1,001 - $15,000SourceFund moves · Holdings as of Jun 30, 2025 (Q2 2025) · Filed Aug 12, 2025
Segall Bryant & Hamill, LLC disclosed an increased position in GMED for Q2 2025SourceFund moves · Holdings as of Jun 30, 2025 (Q2 2025) · Filed Aug 11, 2025
Artemis Investment Management LLP disclosed a reduced position in GMED for Q2 2025Source